Next-generation antivenom fights India’s deadliest snakes
A recent trial in mice has illuminated a potential solution to India's antivenom challenges, addressing a significant health issue in a country often termed the ‘snakebite capital of the world.’ This promising development could significantly enhance treatments for snakebite victims, bringing hope for better health outcomes and reduced fatalities.
India, the ‘snakebite capital of the world’, has an antivenom problem. A trial in mice points to a potential solution
The Telegraph
